<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id><journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id><journal-id journal-id-type="publisher-id">MD</journal-id><journal-title-group><journal-title>Medicine</journal-title></journal-title-group><issn pub-type="ppub">0025-7974</issn><issn pub-type="epub">1536-5964</issn><publisher><publisher-name>Lippincott Williams &#x00026; Wilkins</publisher-name><publisher-loc>Hagerstown, MD</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40388761</article-id><article-id pub-id-type="pmc">PMC12091657</article-id>
<article-id pub-id-type="publisher-id">MD-D-24-15589</article-id><article-id pub-id-type="art-access-id">00042</article-id><article-id pub-id-type="doi">10.1097/MD.0000000000042524</article-id><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version><article-categories><subj-group subj-group-type="heading"><subject>4900</subject></subj-group><subj-group><subject>Research Article</subject><subject>Clinical Case Report</subject></subj-group></article-categories><title-group><article-title>Pulmonary nocardiosis with hilar mass misdiagnosed as lung cancer: A case report</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0007-8083-2569</contrib-id><name><surname>Liu</surname><given-names>Qian</given-names></name><degrees>MM</degrees><email>LIUBINGabc@163.com</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Qian</given-names></name><degrees>MM</degrees><email>LiQian123@163.com</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Bing</given-names></name><degrees>MM</degrees><email>LIUBINGabc@163.com</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0005-9759-5841</contrib-id><name><surname>Fu</surname><given-names>Tian</given-names></name><degrees>MM</degrees><xref rid="aff1" ref-type="aff">a</xref><xref rid="c1" ref-type="corresp">*</xref></contrib><aff id="aff1"><label>a</label>Department of Pulmonary and Critical Care Medicine, Jining First People&#x02019;s Hospital, Jining, Shandong Province, China.</aff></contrib-group><author-notes><corresp id="c1"><label>*</label>Correspondence: Tian Fu, Department of Pulmonary and Critical Care Medicine, Jining First People&#x02019;s Hospital, No. 6 Jiankang Road, Rencheng District, Jining Shandong Province 272000, China (e-mail: <email xlink:href="ftftabc@163.com">ftftabc@163.com</email>).</corresp></author-notes><pub-date pub-type="collection"><day>16</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>16</day><month>5</month><year>2025</year></pub-date><volume>104</volume><issue>20</issue><elocation-id>e42524</elocation-id><history><date date-type="received"><day>11</day><month>12</month><year>2024</year></date><date date-type="received"><day>26</day><month>4</month><year>2025</year></date><date date-type="accepted"><day>2</day><month>5</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 the Author(s). Published by Wolters Kluwer Health, Inc.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License 4.0 (CCBY)</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="medi-104-e42524.pdf"/><abstract><sec><title>Rationale:</title><p>Pulmonary nocardiosis (PN) is an opportunistic infectious disease caused by <italic toggle="yes">Nocardia</italic> of the lungs, which lacks specificity in clinical symptoms and imaging, is rare in individuals with normal immune function, and is highly prone to clinical misdiagnosis and missed diagnosis.</p></sec><sec><title>Patient concerns:</title><p>A 55-year-old woman with normal immune function was admitted to the hospital due to a cough and expectoration for more than 20 days.</p></sec><sec><title>Diagnoses:</title><p>Chest computed tomography revealed a mass in the left hilum and obstructive atelectasis in the lingular segment of the left upper lobe. Initially suspected to be a malignant tumor, bronchoscopy with pathological examination suggested inflammation. Finally, metagenomic next-generation sequencing of pathological tissue confirmed PN.</p></sec><sec><title>Interventions:</title><p>After discharge, the patient regularly took trimethoprim-sulfamethoxazole for anti-infective treatment.</p></sec><sec><title>Outcomes:</title><p>Regular follow-ups with the patient revealed that subsequent chest computed tomography scans showed a gradual reduction in the extent of the lesions, and the patient demonstrated a good clinical response and radiological improvement.</p></sec><sec><title>Lessons:</title><p>This case highlights the diagnostic complexity of PN. The radiological manifestations are diverse, commonly including pulmonary consolidation, nodules, and cavities, making it difficult to differentiate from other diseases. Clinicians need to be vigilant and find appropriate testing methods to improve the diagnostic rate of PN.</p></sec></abstract><kwd-group><kwd>lung cancer</kwd><kwd>metagenomic next-generation sequencing</kwd><kwd>misdiagnosis</kwd><kwd>pulmonary nocardiosis</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta><custom-meta><meta-name>SDC</meta-name><meta-value>T</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>1. Introduction</title><p><italic toggle="yes">Nocardia</italic> is an aerobic, gram-positive, weakly acid-fast staining-positive bacterium. It is ubiquitous in water, air, soil, decaying vegetation, and decomposing organic matter. <italic toggle="yes">Nocardia</italic> mainly enters the human body through inhalation or contact transmission, it is an opportunistic pathogen in individuals with chronic lung disease and in immunocompromised hosts.<sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup> Pulmonary <italic toggle="yes">nocardiosis</italic> (PN) is a pyogenic or granulomatous lung disease caused by <italic toggle="yes">Nocardia</italic> infection. The majority of <italic toggle="yes">Nocardia</italic> infections affect individuals with compromised immune function, often accompanied by abnormalities in cell-mediated immunity. However, some <italic toggle="yes">Nocardia</italic> species can also infect immunocompetent individuals.<sup>[<xref rid="R2" ref-type="bibr">2</xref>]</sup>
<italic toggle="yes">Nocardia</italic> infections can affect various organs, including the brain, lung, skin, and eyes, with the lung being the most commonly involved organ, accounting for approximately 40% to 70% of all <italic toggle="yes">Nocardia</italic> infection cases.<sup>[<xref rid="R3" ref-type="bibr">3</xref>]</sup> The clinical symptoms of PN are nonspecific and include fever, cough, chest pain, dyspnea, anorexia, or weight loss. Radiological imaging can be difficult to distinguish from those of common bacterial infections, invasive pulmonary fungal diseases, tumors, and tuberculosis, the disease may reveal consolidation, nodules, or solitary or multiple lung masses with or without cavitation, potentially leading to misdiagnosis and mistreatment.<sup>[<xref rid="R4" ref-type="bibr">4</xref>]</sup> Currently, our department is treating a patient with PN who presented with no specific clinical symptoms but had imaging findings suggestive of a pulmonary mass. This article reviews the literature to summarize the pathogenesis, clinical imaging manifestations, and treatment of PN, with the aim of providing a reference for early diagnosis and treatment in clinical practice.</p></sec><sec sec-type="cases"><title>2. Case report</title><p>A 55-year-old middle-aged woman was admitted to the hospital on April 22, 2023, with a history of cough and expectoration for over 20 days. Approximately 20 days prior, the patient experienced an unexplained onset of cough, producing a small amount of white sputum accompanied by chest tightness and dyspnea, which were predominant with exertion. There were no complaints of chest pain or hemoptysis. Initial antibiotic treatment at a local clinic was ineffective, prompting a visit to our outpatient department. A chest computed tomography (CT) scan revealed an irregular soft tissue density shadow at the left hilar region, with narrowing of the left main bronchus and the bronchi of the upper and lower lobes of the left lung. Additionally, a segmental consolidation shadow was observed in the lingual segment of the left upper lobe (Fig. <xref rid="F1" ref-type="fig">1</xref>). The patient had a history of partial thyroidectomy and denied any history of hypertension, coronary artery disease, diabetes, or other underlying conditions. There was no history of hepatitis B, tuberculosis, human immunodeficiency virus, or other infectious diseases. Upon admission, the patient&#x02019;s vital signs were normal. The patient was alert and in good spirits. Auscultation of the lungs revealed coarse breath sounds without adventitious sounds or pleural friction rub. The heart rhythm was regular, and no pathological murmurs were heard in any of the valve areas. The abdomen was soft, without tenderness or rebound tenderness, and there was no edema in the lower extremities. Further laboratory tests showed a C-reactive protein level of 14.48&#x02009;mg/L, albumin 37.5&#x02009;g/L, fasting blood glucose 7.76 mmol/L, with no significant abnormalities detected in the complete blood count, liver function, renal function, electrolytes, or coagulation profile. The test for <italic toggle="yes">Cryptococcus neoformans</italic> capsular antigen in blood was negative, suggesting a low likelihood of cryptococcal infection. Additionally, the <italic toggle="yes">Mycobacterium tuberculosis</italic>-specific T-cell detection test yielded negative results, indicating the absence of <italic toggle="yes">M tuberculosis</italic>-specific effector T lymphocytes in the patient&#x02019;s blood specimen and making pulmonary tuberculosis less probable. A comprehensive ultrasound evaluation of the cervical and supraclavicular lymph nodes demonstrated multiple hypoechoic nodules in the left cervical region and left supraclavicular fossa. These nodules exhibited well-defined margins, rounded morphology (long-axis/short-axis ratio&#x02005;&#x0003c;&#x02005;2) and loss of fatty hilum. The sonographic features are indicative of lymph nodes with atypical structures, and ultrasound-guided core needle biopsy is recommended for definitive histopathological characterization. Given the patient&#x02019;s poor response to anti-infective treatment, the presence of atypical structural lymph nodes, and the characteristics of hilar mass on CT imaging, the possibility of lung malignancy was considered high. On April 25th, a contrast enhanced CT scan of the chest was performed, showing no absorption changes in the lesion, with heterogeneous enhancement, and strip-like consolidative atelectasis in the lingular segment of the left upper lobe, suggesting possible lung cancer (Fig. <xref rid="F1" ref-type="fig">1</xref>). Further bronchoscopy revealed mucosal infiltrative changes at the distal end of the left main bronchus, with the lumen almost completely narrowed, preventing the bronchoscope from entering the upper and lower lobes of the left lung (Fig. <xref rid="F2" ref-type="fig">2</xref>). Bronchoscopy also favored a diagnosis of lung cancer. Pathological results on April 29th indicated acute and chronic bronchial inflammation with inflammatory and fibrinous exudates. The histopathological nature of the patient&#x02019;s tissue was difficult to definitively characterize. Immunohistochemical studies were supplemented to assist in diagnosis, with leukocyte common antigen positivity localized to lymphocytes, low molecular weight cytokeratin and cytokeratin positivity localized to epithelial cells, favoring an inflammatory process. The final pathological diagnosis confirmed acute and chronic inflammation of the bronchial mucosa, accompanied by inflammatory infiltrates and fibrinous exudates. Pathologists at Shandong Tumor Hospital reviewed slides and described acute and chronic bronchial inflammation with squamous metaplasia and exudative tissue. Pathology suggested inflammatory disease, and the patient received azithromycin and ceftriaxone for infection during hospitalization but showed little improvement in symptoms. To clarify the nature of the pulmonary lesion, the pathological tissue wax block underwent metagenomic next-generation sequencing (NGS) and detected <italic toggle="yes">Nocardia farcinica</italic> (607 sequences), Supplemental Digital Content, <ext-link xlink:href="https://links.lww.com/MD/O946" ext-link-type="uri">https://links.lww.com/MD/O946</ext-link>. The final diagnosis was PN (<italic toggle="yes">N farcinica</italic>). After discharge, the patient was prescribed oral trimethoprim-sulfamethoxazole (TMP-SMX) at a dose of 2 tablets (400&#x02009;mg sulfamethoxazole/160&#x02009;mg trimethoprim) 4 times daily for a 6-month treatment course. Follow-up outpatient chest CT scans on June 1, 2023 and November 2, 2023 showed a significant reduction in lesion extent and bronchial lumen patency has slightly improved (Fig. <xref rid="F3" ref-type="fig">3</xref>). Another scan on April 14, 2024 (Fig. <xref rid="F3" ref-type="fig">3</xref>) showed roughly similar lesions to the previous scans.</p><fig position="float" id="F1"><label>Figure 1.</label><caption><p>Pretreatment chest CT findings in patient. A mass in the left hilum (yellow arrows) and luminal narrowing of the left main bronchus and left upper/lower lobe bronchi (red arrows). Strip-like consolidative atelectasis in the lingular segment of the left upper lobe (white arrows). CT&#x02005;=&#x02005;computed tomograph.</p></caption><graphic xlink:href="medi-104-e42524-g001" position="float"/></fig><fig position="float" id="F2"><label>Figure 2.</label><caption><p>(A, B) Bronchoscopy reveals infiltrative changes in the mucosa at the end of the left main bronchus, and the lumen being almost completely narrowed.</p></caption><graphic xlink:href="medi-104-e42524-g002" position="float"/></fig><fig position="float" id="F3"><label>Figure 3.</label><caption><p>Chest CT findings after treatment with TMP-SMX in patient. (A, B) June 1, 2023, chest CT showed a significant reduction in lesion extent (yellow arrows), and bronchial lumen patency has slightly improved (red arrows). (C, D) Chest CT scan on November 2, 2023. (E, F) Chest CT scan on April 14, 2024. CT&#x02005;=&#x02005;computed tomography, TMP-SMX&#x02005;=&#x02005;trimethoprim-sulfamethoxazole.</p></caption><graphic xlink:href="medi-104-e42524-g003" position="float"/></fig></sec><sec sec-type="discussion"><title>3. Discussion</title><p><italic toggle="yes">Nocardia</italic> was 1st proposed by French veterinarian and microbiologist Edmond Nocard, it commonly invades the human body through the respiratory, digestive, or skin systems, leading to localized or systemic disseminated suppurative inflammation.<sup>[<xref rid="R5" ref-type="bibr">5</xref>]</sup> The Centers for Disease Control and Prevention estimates that there are 500 to 1000 new cases of <italic toggle="yes">Nocardia</italic> infection annually in the United States.<sup>[<xref rid="R6" ref-type="bibr">6</xref>]</sup> The incidence of Nocardiosis is age-specific, most common among elderly patients; the average age of nocardiosis patients is 61.6 years, with 44.0% of patients aged&#x02005;&#x02265;&#x02005;65 years and 9.3%&#x02005;&#x0003c;&#x02005;45 years. The male-to-female ratio is approximately 1.44:1.<sup>[<xref rid="R7" ref-type="bibr">7</xref>]</sup> Among the 119 named species of <italic toggle="yes">Nocardia</italic>, 54 are associated with human infections, and the number of officially published and named subspecies of <italic toggle="yes">Nocardia</italic> has reached 120. The 6 most common species complexes are the <italic toggle="yes">Nocardia nova</italic> complex, the <italic toggle="yes">Nocardia cyriacigeorgica</italic> complex, the <italic toggle="yes">N farcinica</italic> complex, the <italic toggle="yes">Nocardia brasiliensis</italic> complex, the <italic toggle="yes">Nocardia abscessus</italic> complex, and the <italic toggle="yes">Nocardia transvalensis</italic> complex.<sup>[<xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R9" ref-type="bibr">9</xref>]</sup> The pathogenic mechanism of <italic toggle="yes">Nocardia</italic> is not yet fully understood, but some studies suggest that its pathogenicity is related to its ability to prevent phagocytosis, specifically by inhibiting the fusion of phagosomes and lysosomes to block the bactericidal action of phagocytic cells, by blocking phagosome acidification to resist the microbial killing action of phagocytic cells, and by releasing superoxide dismutase to resist the respiratory burst.<sup>[<xref rid="R10" ref-type="bibr">10</xref>]</sup></p><p><italic toggle="yes">Nocardia</italic> infections are commonly observed in immunosuppressed patients, with frequent underlying causes including malignancies, organ or hematopoietic stem cell transplantation, and human immunodeficiency virus infection. Other associated diseases include diabetes, chronic granulomatous disease, pulmonary alveolar proteinosis, inflammatory bowel disease, chronic obstructive pulmonary disease, and tuberculosis.<sup>[<xref rid="R11" ref-type="bibr">11</xref>]</sup> In most cases, <italic toggle="yes">Nocardia</italic> infections cannot be rapidly diagnosed due to lack of specific clinical symptoms. The clinical manifestations of <italic toggle="yes">Nocardia</italic> infection, commonly referred to as primary <italic toggle="yes">Nocardia</italic> pneumonia, primarily include fever, cough with sputum, hemoptysis, chest pain, dyspnea, and anorexia, with some patients exhibiting no clinical symptoms.<sup>[<xref rid="R12" ref-type="bibr">12</xref>]</sup> In this case, the patient presented with cough, sputum production, and a pulmonary mass, lacking other specific symptoms, and had suboptimal response to anti-inflammatory treatment, leading to consideration of neoplastic disease.</p><p>The chest imaging manifestations of PN are diverse, including consolidation, cavitary and non-cavitary pulmonary nodules/masses, ground glass opacities, centrilobular nodules, interlobular septal thickening, &#x0201c;crazy paving&#x0201d; pattern, pleural effusion, and pleural traction, with the most common imaging finding being nodules or masses. Additionally, lymphadenopathy is observed in some patients.<sup>[<xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R14" ref-type="bibr">14</xref>]</sup> Kurahara et al,<sup>[<xref rid="R15" ref-type="bibr">15</xref>]</sup> in 2014 conducted an imaging analysis on 59 patients with PN, of which 28 showed airspace consolidation, 13 showed nodules, 3 showed consolidation with cavity, 2 showed cavity, 1 showed pleural effusion, and 12 showed radiographic patterns were indeterminate. The combination of these imaging findings with nonspecific clinical symptoms often leads to misdiagnosis as tuberculosis, fungal infections, or malignancies. In a meta-analysis,<sup>[<xref rid="R16" ref-type="bibr">16</xref>]</sup> 4 studies with a total sample size of 476 suspected tuberculosis patients were included, revealing a prevalence of PN ranging from 1.7% to 6.7%. Chronic structural lung diseases and long-term use of immunosuppressive agents are risk factors for PN. Although CT manifestations are highly heterogeneous, the presence of nodules, patchy consolidation, and cavities, especially in the context of extrapulmonary infections such as brain and subcutaneous tissue, should raise clinical suspicion. The incidence of cavities is significantly higher in immunosuppressed patients.<sup>[<xref rid="R17" ref-type="bibr">17</xref>]</sup> The 1-year mortality rate of nocardiosis ranges from 15.8% to 24.5%, varying according to the type of infecting organism and the patient&#x02019;s immune status.<sup>[<xref rid="R18" ref-type="bibr">18</xref>]</sup> Prognosis depends on the extent of the disease and complications, but early diagnosis and timely treatment can reduce mortality and recurrence risks.<sup>[<xref rid="R19" ref-type="bibr">19</xref>]</sup>
<italic toggle="yes">Nocardia</italic> can be isolated from respiratory secretions, blood, pus, or tissue samples through culture or molecular techniques, which are essential for the diagnosis of PN. Rapid molecular identification of <italic toggle="yes">Nocardia</italic> can be achieved through methods such as polymerase chain reaction, deoxyribonucleic acid probes, deoxyribonucleic acid sequencing, pyrosequencing, ribotyping, and restriction fragment length polymorphism analysis.<sup>[<xref rid="R5" ref-type="bibr">5</xref>]</sup> Diagnosis requires clinical symptoms, as well as microbiological idenification of <italic toggle="yes">Nocardia</italic> species from clinical specimens such as sputum, bronchoalveolar lavage fluid, fine needle aspiration, or lung biopsy, <italic toggle="yes">Nocardia amamiensis</italic> was detected by 16S ribosomal ribonucleic acid sequencing of the sputum specimen are reported by Kanakan et al.<sup>[<xref rid="R4" ref-type="bibr">4</xref>]</sup> 16S ribosomal ribonucleic acid sequencing as a simpler alternative to metagenomic NGS which may not be available. In this case, the diagnosis was confirmed by performing metagenomic NGS on the pathological tissue.</p><p>Since 1950, sulfonamides have remained the cornerstone of <italic toggle="yes">Nocardia</italic> infection treatment, with TMP-SMX most common.<sup>[<xref rid="R20" ref-type="bibr">20</xref>]</sup> Several other drugs show activity against <italic toggle="yes">Nocardia</italic>, including carbapenems, ceftriaxone, amikacin, minocycline, fluoroquinolones, and amoxicillin-clavulanate. Linezolid and tedizolid expand treatment options and are active against most <italic toggle="yes">Nocardia</italic> species in vitro.<sup>[<xref rid="R21" ref-type="bibr">21</xref>]</sup> Combination therapy is often used for prolonged disease course, severe or disseminated infections. Immunocompromised patients require longer treatment. CT consolidation and nodules indicate poorer prognosis, potentially progressive pulmonary <italic toggle="yes">Nocardia</italic> infection, and more aggressive treatment is recommended.<sup>[<xref rid="R22" ref-type="bibr">22</xref>]</sup> The patient was initially treated for lung cancer and obstructive pneumonia with ineffective common bacterial antibiotics. After <italic toggle="yes">Nocardia</italic> infection diagnosis and TMP-SMX treatment, chest CT lesion absorption improved significantly.</p><p>PN is a rare opportunistic infectious disease. In immunocompetent patients, the diagnosis of <italic toggle="yes">Nocardia</italic> is particularly challenging due to the nonspecific nature of symptoms and imaging findings. Therefore, in patients without immunosuppression, especially those with frequent exacerbations of chronic obstructive pulmonary disease, if symptoms and imaging features suggestive of lung cancer are present, it is crucial to be vigilant for PN. To accurately diagnose diseases caused by rare bacterial species, repeated sampling and the identification of appropriate testing methods are paramount.</p></sec><sec><title>Author contributions</title><p><bold>Data curation:</bold> Qian Liu, Qian Li, Bing Liu, Tian Fu.</p><p><bold>Conceptualization:</bold> Tian Fu.</p><p><bold>Investigation:</bold> Qian Liu, Tian Fu.</p><p><bold>Supervision:</bold> Bing Liu, Tian Fu.</p><p><bold>Writing &#x02013; original draft:</bold> Qian Liu, Tian Fu.</p><p><bold>Writing &#x02013; review &#x00026; editing:</bold> Qian Liu, Tian Fu.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><fig id="s001" position="anchor"><media xlink:href="medi-104-e42524-s001.pdf"/></fig></sec></body><back><fn-group><fn fn-type="abbr"><p>
<def-list><title>Abbreviations:</title><def-item><term>CT</term><def><p>computed tomography</p></def></def-item><def-item><term>PN</term><def><p>pulmonary nocardiosis</p></def></def-item><def-item><term>TMP-SMX</term><def><p>trimethoprim-sulfamethoxazole</p></def></def-item></def-list>
</p></fn></fn-group><fn-group><fn fn-type="other"><p>The patient provided written informed consent for the publication of his clinical details and radiological images while maintaining anonymity.</p></fn><fn fn-type="other"><p>Ethical review and approval were not required because this is not a clinical study but a case study in accordance with the local legislation and institutional requirements.</p></fn><fn fn-type="COI-statement"><p>The authors have no funding and conflicts of interest to disclose.</p></fn><fn fn-type="other"><p>Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.</p></fn><fn fn-type="supplementary-material"><p>Supplemental Digital Content is available for this article.</p></fn><fn fn-type="other"><p>How to cite this article: Liu Q, Li Q, Liu B, Fu T. Pulmonary nocardiosis with hilar mass misdiagnosed as lung cancer: A case report. Medicine 2025;104:20(e42524).</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNeil</surname><given-names>MM</given-names></name><name><surname>Brown</surname><given-names>JM</given-names></name></person-group>. <article-title>The medically important aerobic actinomycetes: epidemiology and microbiology.</article-title>
<source>Clin Microbiol Rev</source>. <year>1994</year>;<volume>7</volume>:<fpage>357</fpage>&#x02013;<lpage>417</lpage>.<pub-id pub-id-type="pmid">7923055</pub-id>
</mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>J</given-names></name><name><surname>Guan</surname><given-names>W</given-names></name><name><surname>Hu</surname><given-names>A</given-names></name><name><surname>Luo</surname><given-names>Q</given-names></name></person-group>. <article-title>Mild pulmonary nocardiosis caused by Nocardia terpenica in an immunocompetent patient.</article-title>
<source>Intern Med</source>. <year>2023</year>;<volume>62</volume>:<fpage>2911</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">36792184</pub-id>
</mixed-citation></ref><ref id="R3"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>K</given-names></name><name><surname>Noguchi</surname><given-names>S</given-names></name><name><surname>Naito</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Pulmonary nocardiosis caused by Nocardia exalbida in a patient with lung cancer and radiation pneumonitis: a case report and literature review.</article-title>
<source>Intern Med</source>. <year>2019</year>;<volume>58</volume>:<fpage>1605</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="pmid">30713323</pub-id>
</mixed-citation></ref><ref id="R4"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanakan</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Kaur</surname><given-names>U</given-names></name><etal/></person-group>. <article-title>Case report: Nocardia amamiensis infection leading to worsening of chronic obstructive pulmonary disease symptoms in an elderly man.</article-title>
<source>Am J Trop Med Hyg</source>. <year>2023</year>;<volume>109</volume>:<fpage>1137</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="pmid">37696514</pub-id>
</mixed-citation></ref><ref id="R5"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duggal</surname><given-names>SD</given-names></name><name><surname>Chugh</surname><given-names>TD</given-names></name></person-group>. <article-title>Nocardiosis: a neglected disease.</article-title>
<source>Med Princ Pract</source>. <year>2020</year>;<volume>29</volume>:<fpage>514</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="pmid">32422637</pub-id>
</mixed-citation></ref><ref id="R6"><label>[6]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Traxler</surname><given-names>RM</given-names></name><name><surname>Bell</surname><given-names>ME</given-names></name><name><surname>Lasker</surname><given-names>B</given-names></name><name><surname>Headd</surname><given-names>B</given-names></name><name><surname>Shieh</surname><given-names>WJ</given-names></name><name><surname>McQuiston</surname><given-names>JR</given-names></name></person-group>. <article-title>Updated review on <italic toggle="yes">Nocardia</italic> species: 2006-2021.</article-title>
<source>Clin Microbiol Rev</source>. <year>2022</year>;<volume>35</volume>:<fpage>e0002721</fpage>.<pub-id pub-id-type="pmid">36314911</pub-id>
</mixed-citation></ref><ref id="R7"><label>[7]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Cui</surname><given-names>Q</given-names></name><etal/></person-group>. <article-title>Epidemiology and antimicrobial resistance profiles of the <italic toggle="yes">Nocardia</italic> species in China, 2009 to 2021.</article-title>
<source>Microbiol Spectr</source>. <year>2022</year>;<volume>10</volume>:<fpage>e0156021</fpage>.<pub-id pub-id-type="pmid">35234511</pub-id>
</mixed-citation></ref><ref id="R8"><label>[8]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamdi</surname><given-names>AM</given-names></name><name><surname>Fida</surname><given-names>M</given-names></name><name><surname>Deml</surname><given-names>SM</given-names></name><name><surname>Abu Saleh</surname><given-names>OM</given-names></name><name><surname>Wengenack</surname><given-names>NL</given-names></name></person-group>. <article-title>Retrospective analysis of antimicrobial susceptibility profiles of <italic toggle="yes">Nocardia</italic> species from a tertiary hospital and reference laboratory, 2011 to 2017.</article-title>
<source>Antimicrob Agents Chemother</source>. <year>2020</year>;<volume>64</volume>:<fpage>e01868</fpage>&#x02013;<lpage>19</lpage>.<pub-id pub-id-type="pmid">31818815</pub-id>
</mixed-citation></ref><ref id="R9"><label>[9]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>YE</given-names></name><name><surname>Chen</surname><given-names>SC</given-names></name><name><surname>Halliday</surname><given-names>CL</given-names></name></person-group>. <article-title>Antimicrobial susceptibility profiles and species distribution of medically relevant Nocardia species: results from a large tertiary laboratory in Australia.</article-title>
<source>J Glob Antimicrob Resist</source>. <year>2020</year>;<volume>20</volume>:<fpage>110</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">31400449</pub-id>
</mixed-citation></ref><ref id="R10"><label>[10]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia Rueda</surname><given-names>JE</given-names></name><name><surname>Garc&#x000ed;a Rueda</surname><given-names>KY</given-names></name><name><surname>Berm&#x000fa;dez Fl&#x000f3;rez</surname><given-names>AM</given-names></name><name><surname>Pe&#x000f1;a Mej&#x000ed;a</surname><given-names>LA</given-names></name><name><surname>Cardona Palacio</surname><given-names>A</given-names></name><name><surname>Casta&#x000f1;o Ruiz</surname><given-names>W</given-names></name></person-group>. <article-title>Nocardia in an immunocompetent patient simulating pulmonary carcinoma: a case report and literature review.</article-title>
<source>Cureus</source>. <year>2024</year>;<volume>16</volume>:<fpage>e64491</fpage>.<pub-id pub-id-type="pmid">39139318</pub-id>
</mixed-citation></ref><ref id="R11"><label>[11]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortiz</surname><given-names>J</given-names></name><name><surname>Jover</surname><given-names>F</given-names></name><name><surname>Ortiz de la Tabla</surname><given-names>V</given-names></name><name><surname>Delgado</surname><given-names>E</given-names></name></person-group>. <article-title>Pulmonary nocardiosis after covid-19 infection: case report and literature review.</article-title>
<source>Rev Esp Quimioter</source>. <year>2023</year>;<volume>36</volume>:<fpage>421</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">37101409</pub-id>
</mixed-citation></ref><ref id="R12"><label>[12]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takiguchi</surname><given-names>Y</given-names></name><name><surname>Ishizaki</surname><given-names>S</given-names></name><name><surname>Kobayashi</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Pulmonary nocardiosis: a clinical analysis of 30 cases.</article-title>
<source>Intern Med</source>. <year>2017</year>;<volume>56</volume>:<fpage>1485</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="pmid">28626172</pub-id>
</mixed-citation></ref><ref id="R13"><label>[13]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyaoka</surname><given-names>C</given-names></name><name><surname>Nakamoto</surname><given-names>K</given-names></name><name><surname>Shirai</surname><given-names>T</given-names></name><name><surname>Miyamoto</surname><given-names>M</given-names></name><name><surname>Sasaki</surname><given-names>Y</given-names></name><name><surname>Ohta</surname><given-names>K</given-names></name></person-group>. <article-title>Pulmonary nocardiosis caused by <italic toggle="yes">Nocardia exalbida</italic> mimicking lung cancer.</article-title>
<source>Respirol Case Rep</source>. <year>2019</year>;<volume>7</volume>:<fpage>e00458</fpage>.<pub-id pub-id-type="pmid">31304018</pub-id>
</mixed-citation></ref><ref id="R14"><label>[14]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al Umairi</surname><given-names>RS</given-names></name><name><surname>Pandak</surname><given-names>N</given-names></name><name><surname>Al Busaidi</surname><given-names>M</given-names></name></person-group>. <article-title>The findings of pulmonary nocardiosis on chest high resolution computed tomography: single centre experience and review of literature.</article-title>
<source>Sultan Qaboos Univ Med J</source>. <year>2022</year>;<volume>22</volume>:<fpage>357</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="pmid">36072066</pub-id>
</mixed-citation></ref><ref id="R15"><label>[15]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurahara</surname><given-names>Y</given-names></name><name><surname>Tachibana</surname><given-names>K</given-names></name><name><surname>Tsuyuguchi</surname><given-names>K</given-names></name><name><surname>Akira</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Hayashi</surname><given-names>S</given-names></name></person-group>. <article-title>Pulmonary nocardiosis: a clinical analysis of 59 cases.</article-title>
<source>Respir Investig</source>. <year>2014</year>;<volume>52</volume>:<fpage>160</fpage>&#x02013;<lpage>6</lpage>.</mixed-citation></ref><ref id="R16"><label>[16]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehrabadi</surname><given-names>SM</given-names></name><name><surname>Taraghian</surname><given-names>M</given-names></name><name><surname>Pirouzi</surname><given-names>A</given-names></name><name><surname>Khaledi</surname><given-names>A</given-names></name><name><surname>Neshani</surname><given-names>A</given-names></name><name><surname>Rashki</surname><given-names>S</given-names></name></person-group>. <article-title>Pulmonary nocardiosis in suspected tuberculosis patients: a systematic review and meta-analysis of cross-sectional studies.</article-title>
<source>Ethiop J Health Sci</source>. <year>2020</year>;<volume>30</volume>:<fpage>293</fpage>&#x02013;<lpage>300</lpage>.<pub-id pub-id-type="pmid">32165819</pub-id>
</mixed-citation></ref><ref id="R17"><label>[17]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>R</given-names></name><name><surname>Wen</surname><given-names>Y</given-names></name><name><surname>Liufu</surname><given-names>Y</given-names></name><name><surname>Pan</surname><given-names>X</given-names></name><name><surname>Guan</surname><given-names>Y</given-names></name></person-group>. <article-title>The computed tomography findings and follow-up course of pulmonary nocardiosis.</article-title>
<source>J Comput Assist Tomogr</source>. <year>2023</year>;<volume>47</volume>:<fpage>418</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="pmid">37185005</pub-id>
</mixed-citation></ref><ref id="R18"><label>[18]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yetmar</surname><given-names>ZA</given-names></name><name><surname>Khodadadi</surname><given-names>RB</given-names></name><name><surname>Chesdachai</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Mortality after nocardiosis: risk factors and evaluation of disseminated infection.</article-title>
<source>Open Forum Infect Dis</source>. <year>2023</year>;<volume>10</volume>:<fpage>ofad409</fpage>.<pub-id pub-id-type="pmid">37577117</pub-id>
</mixed-citation></ref><ref id="R19"><label>[19]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lynch</surname><given-names>JP</given-names><suffix>3rd</suffix></name><name><surname>Reid</surname><given-names>G</given-names></name><name><surname>Clark</surname><given-names>NM</given-names></name></person-group>. <article-title>Nocardia spp.: a rare cause of pneumonia globally.</article-title>
<source>Semin Respir Crit Care Med</source>. <year>2020</year>;<volume>41</volume>:<fpage>538</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="pmid">32629491</pub-id>
</mixed-citation></ref><ref id="R20"><label>[20]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>JW</given-names></name></person-group>. <article-title>Nocardiosis: updates and clinical overview.</article-title>
<source>Mayo Clin Proc</source>. <year>2012</year>;<volume>87</volume>:<fpage>403</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">22469352</pub-id>
</mixed-citation></ref><ref id="R21"><label>[21]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Margalit</surname><given-names>I</given-names></name><name><surname>Lebeaux</surname><given-names>D</given-names></name><name><surname>Tishler</surname><given-names>O</given-names></name><etal/></person-group>. <article-title>How do I manage nocardiosis?</article-title>
<source>Clin Microbiol Infect</source>. <year>2021</year>;<volume>27</volume>:<fpage>550</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">33418019</pub-id>
</mixed-citation></ref><ref id="R22"><label>[22]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HN</given-names></name><name><surname>Do</surname><given-names>KH</given-names></name><name><surname>Kim</surname><given-names>EY</given-names></name><etal/></person-group>. <article-title>Comparative analysis of CT findings and clinical outcomes in adult patients with disseminated and localized pulmonary nocardiosis.</article-title>
<source>J Korean Med Sci</source>. <year>2024</year>;<volume>39</volume>:<fpage>e107</fpage>.<pub-id pub-id-type="pmid">38529577</pub-id>
</mixed-citation></ref></ref-list></back></article>